Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interferon and herpes]

R Wyler

    Zeitschrift Fur Hautkrankheiten
    |May 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Exogenous interferon, a non-toxic antiviral protein, shows promise in inhibiting virus multiplication. While production is costly, this therapy avoids toxicity issues seen in endogenous methods, offering a preferred treatment for viral infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pharmacological characterization of Ro 63-1908 (1-[2-(4-hydroxy-phenoxy)-ethyl]-4-(4-methyl-benzyl)-piperidin-4-ol), a novel subtype-selective N-methyl-D-aspartate antagonist.

    The Journal of pharmacology and experimental therapeutics·2002
    Same author

    A study of the nicotinic agonist SIB-1553A on locomotion and attention as measured by the five-choice serial reaction time task.

    Pharmacology, biochemistry, and behavior·2002
    Same author

    Discovery of (R)-1-[2-hydroxy-3-(4-hydroxy-phenyl)-propyl]-4-(4-methyl-benzyl)-piperidin-4-ol: a novel NR1/2B subtype selective NMDA receptor antagonist.

    Bioorganic & medicinal chemistry letters·2001
    Same author

    Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine.

    The Journal of pharmacology and experimental therapeutics·2000
    Same author

    The alpha4beta2 agonist SIB 1765F, but not the alpha7 agonist AR-R 17779, cross-sensitises to the psychostimulant effects of nicotine.

    Psychopharmacology·2000
    Same author

    Pharmacologic evaluation of the discriminative stimulus of metachlorophenylpiperazine.

    Pharmacology, biochemistry, and behavior·1996
    Same journal

    [Acne vulgaris: morphologic, endocrinologic and psychosomatic aspects].

    Zeitschrift fur Hautkrankheiten·1990
    Same journal

    [Anti-androgen treatment of hirsutism with cyproterone acetate].

    Zeitschrift fur Hautkrankheiten·1990
    Same journal

    [Changes in sunscreening products in West Germany between 1988 and 1989/90].

    Zeitschrift fur Hautkrankheiten·1990
    Same journal

    [Effect of treatment with salt from the Dead Sea (Tomesa therapy) on epidermal Langerhans cells--a clinical study].

    Zeitschrift fur Hautkrankheiten·1990
    Same journal

    [DNA determination by cytophotometry in bowenoid papules in comparison with condylomata acuminata and Bowen's disease].

    Zeitschrift fur Hautkrankheiten·1990
    Same journal

    [Adverse drug reactions on hair].

    Zeitschrift fur Hautkrankheiten·1990
    See all related articles

    Area of Science:

    • Biochemistry
    • Virology
    • Immunology

    Context:

    • Interferon is a cellular protein with potent antiviral properties.
    • Exogenous interferon therapy involves administering externally produced interferon.
    • Endogenous interferon therapy stimulates the body's natural production, often with toxic side effects.

    Purpose:

    • To evaluate the efficacy and safety of exogenous interferon as an antiviral treatment.
    • To compare exogenous interferon therapy with endogenous interferon therapy.
    • To highlight the advantages of exogenous interferon due to its non-toxic nature.

    Summary:

    • Exogenous interferon effectively inhibits viral multiplication without significant toxicity.
    • Clinical trials for herpes virus infections show encouraging results for exogenous interferon.

    Related Experiment Videos

  • Further double-blind studies are required to confirm these findings.
  • Industrial-scale production methods are crucial for widespread clinical application.

    • Impact:

    • Exogenous interferon represents a promising non-toxic therapeutic strategy against viral infections.
    • Successful large-scale production could lead to a new standard of care for viral diseases.
    • This research paves the way for advanced antiviral treatments with improved safety profiles.